Loading…
Lobbying Spend
—
Filings
16
Firms Hired
1
Active Period
2015–2019
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Restoring the Patient's Voice Act of 2017
2018 · fourth_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation HR 4841 - Safe Prescribing Act of 2018 - support for standardizing electronic prior authorization for medicare Part D Medicare Part B and Part D - education on CMS proposals (focused on increased usage of utilization management tools)
Client expense: — · Firm income: $30,000
Matched citations: HR 2077
Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018
2018 · fourth_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation HR 4841 - Safe Prescribing Act of 2018 - support for standardizing electronic prior authorization for medicare Part D Medicare Part B and Part D - education on CMS proposals (focused on increased usage of utilization management tools)
Client expense: — · Firm income: $30,000
Matched citations: HR 4841
Restoring the Patient's Voice Act of 2017
2018 · third_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation HR 4841 - Safe Prescribing Act of 2018 - support for standardizing electronic prior authorization for medicare Part D Medicare Part B and Part D - support for existing programs PL 115-262 (S. 2553) - Know the Lowest Price Act of 2018 PL 115-263 (S 2554) - Patient Right to Know Drug Prices Act (Gag rule) Education around patient access to prescribed medicines
Client expense: — · Firm income: $30,000
Matched citations: HR 2077
Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018
2018 · third_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation HR 4841 - Safe Prescribing Act of 2018 - support for standardizing electronic prior authorization for medicare Part D Medicare Part B and Part D - support for existing programs PL 115-262 (S. 2553) - Know the Lowest Price Act of 2018 PL 115-263 (S 2554) - Patient Right to Know Drug Prices Act (Gag rule) Education around patient access to prescribed medicines
Client expense: — · Firm income: $30,000
Matched citations: HR 4841
Know the Lowest Price Act of 2018
2018 · third_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation HR 4841 - Safe Prescribing Act of 2018 - support for standardizing electronic prior authorization for medicare Part D Medicare Part B and Part D - support for existing programs PL 115-262 (S. 2553) - Know the Lowest Price Act of 2018 PL 115-263 (S 2554) - Patient Right to Know Drug Prices Act (Gag rule) Education around patient access to prescribed medicines
Client expense: — · Firm income: $30,000
Matched citations: S. 2553
Patient Right to Know Drug Prices Act
2018 · third_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation HR 4841 - Safe Prescribing Act of 2018 - support for standardizing electronic prior authorization for medicare Part D Medicare Part B and Part D - support for existing programs PL 115-262 (S. 2553) - Know the Lowest Price Act of 2018 PL 115-263 (S 2554) - Patient Right to Know Drug Prices Act (Gag rule) Education around patient access to prescribed medicines
Client expense: — · Firm income: $30,000
Matched citations: S 2554
Restoring the Patient's Voice Act of 2017
2018 · second_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation HR 4841 - Safe Prescribing Act of 2018 - support for standardizing electronic prior authorization for medicare Part D Medicare Part B and Part D - support for existing programs HR 4710 - 340B Pause Act - education on 340B program and impact on patient access S 2453 - Ensuring the Value of the 340B program - education on 340B program and impact on patient access S 2554 - Patient Right to Know Drug Prices Act (Gag rule) Education around patient access to prescribed medicines
Client expense: — · Firm income: $30,000
Matched citations: HR 2077
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation HR 4841 - Safe Prescribing Act of 2018 - support for standardizing electronic prior authorization for medicare Part D Medicare Part B and Part D - support for existing programs HR 4710 - 340B Pause Act - education on 340B program and impact on patient access S 2453 - Ensuring the Value of the 340B program - education on 340B program and impact on patient access S 2554 - Patient Right to Know Drug Prices Act (Gag rule) Education around patient access to prescribed medicines
Client expense: — · Firm income: $30,000
Matched citations: HR 4710
Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018
2018 · second_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation HR 4841 - Safe Prescribing Act of 2018 - support for standardizing electronic prior authorization for medicare Part D Medicare Part B and Part D - support for existing programs HR 4710 - 340B Pause Act - education on 340B program and impact on patient access S 2453 - Ensuring the Value of the 340B program - education on 340B program and impact on patient access S 2554 - Patient Right to Know Drug Prices Act (Gag rule) Education around patient access to prescribed medicines
Client expense: — · Firm income: $30,000
Matched citations: HR 4841
Ensuring the Value of the 340B Program Act of 2018
2018 · second_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation HR 4841 - Safe Prescribing Act of 2018 - support for standardizing electronic prior authorization for medicare Part D Medicare Part B and Part D - support for existing programs HR 4710 - 340B Pause Act - education on 340B program and impact on patient access S 2453 - Ensuring the Value of the 340B program - education on 340B program and impact on patient access S 2554 - Patient Right to Know Drug Prices Act (Gag rule) Education around patient access to prescribed medicines
Client expense: — · Firm income: $30,000
Matched citations: S 2453
Patient Right to Know Drug Prices Act
2018 · second_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation HR 4841 - Safe Prescribing Act of 2018 - support for standardizing electronic prior authorization for medicare Part D Medicare Part B and Part D - support for existing programs HR 4710 - 340B Pause Act - education on 340B program and impact on patient access S 2453 - Ensuring the Value of the 340B program - education on 340B program and impact on patient access S 2554 - Patient Right to Know Drug Prices Act (Gag rule) Education around patient access to prescribed medicines
Client expense: — · Firm income: $30,000
Matched citations: S 2554
Restoring the Patient's Voice Act of 2017
2018 · first_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation HR 4841 - Safe Prescribing Act of 2018 - support for standardizing electronic prior authorization for medicare Part D Medicare Part B and Part D - support for existing programs HR 4710 - 340B Pause Act - education on 340B program and impact on patient access S 2453 - Ensuring the Value of the 340B program - education on 340B program and impact on patient access Education around patient access to prescribed medicines
Client expense: — · Firm income: $30,000
Matched citations: HR 2077
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation HR 4841 - Safe Prescribing Act of 2018 - support for standardizing electronic prior authorization for medicare Part D Medicare Part B and Part D - support for existing programs HR 4710 - 340B Pause Act - education on 340B program and impact on patient access S 2453 - Ensuring the Value of the 340B program - education on 340B program and impact on patient access Education around patient access to prescribed medicines
Client expense: — · Firm income: $30,000
Matched citations: HR 4710
Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018
2018 · first_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation HR 4841 - Safe Prescribing Act of 2018 - support for standardizing electronic prior authorization for medicare Part D Medicare Part B and Part D - support for existing programs HR 4710 - 340B Pause Act - education on 340B program and impact on patient access S 2453 - Ensuring the Value of the 340B program - education on 340B program and impact on patient access Education around patient access to prescribed medicines
Client expense: — · Firm income: $30,000
Matched citations: HR 4841
Ensuring the Value of the 340B Program Act of 2018
2018 · first_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation HR 4841 - Safe Prescribing Act of 2018 - support for standardizing electronic prior authorization for medicare Part D Medicare Part B and Part D - support for existing programs HR 4710 - 340B Pause Act - education on 340B program and impact on patient access S 2453 - Ensuring the Value of the 340B program - education on 340B program and impact on patient access Education around patient access to prescribed medicines
Client expense: — · Firm income: $30,000
Matched citations: S 2453
Restoring the Patient's Voice Act of 2017
2017 · fourth_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation CMS Healthcare Common Procedure Coding System (HCPCS) for biosimilar medicines Education around patient access to prescribed medicines
Client expense: — · Firm income: $30,000
Matched citations: HR 2077
Restoring the Patient's Voice Act of 2017
2017 · third_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) PL 115-52 FDA Reauthorization Act of 2017 - passage and inclusion of clinical trial awareness provisions HR 2077 - Restoring the Patient's Voice Act of 2017 - support for federal step therapy legislation
Client expense: — · Firm income: $30,000
Matched citations: HR 2077
FDA Reauthorization Act of 2017
2017 · second_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2430/S934 FDA Reauthorization Act of2017 - inclusion of clinical trial awareness provisions
Client expense: — · Firm income: $30,000
Matched citations: HR 2430
FDA Reauthorization Act of 2017
2017 · second_quarter · Firm: WOODBERRY ASSOCIATES
Biologic and biosimilar medicines - access and uptake (education on FDA guidelines) HR 2430/S934 FDA Reauthorization Act of2017 - inclusion of clinical trial awareness provisions
Client expense: — · Firm income: $30,000
Matched citations: S934
Further Continuing and Security Assistance Appropriations Act, 2017
2016 · fourth_quarter · Firm: WOODBERRY ASSOCIATES
PL 114-255 (HR 34) - 21st Century Cures -- provisions supporting clinical trial research and CDC funding Senate Medical Innovation legislation Clinical Trials -- supporting a federal campaign to promote clinical trial participation Biologic medicines - supporting transparent naming, labeling and indication extrapolation PL 114-254 (HR 2028) Continuing Resolution - funding to implement provisions of the Comprehensive Addiction & Recovery Act (CARA) S. 3040 Labor/HHS/ED Appropriations - support for clinical trials and medical research
Client expense: — · Firm income: $30,000
Matched citations: HR 2028
PL 114-255 (HR 34) - 21st Century Cures -- provisions supporting clinical trial research and CDC funding Senate Medical Innovation legislation Clinical Trials -- supporting a federal campaign to promote clinical trial participation Biologic medicines - supporting transparent naming, labeling and indication extrapolation PL 114-254 (HR 2028) Continuing Resolution - funding to implement provisions of the Comprehensive Addiction & Recovery Act (CARA) S. 3040 Labor/HHS/ED Appropriations - support for clinical trials and medical research
Client expense: — · Firm income: $30,000
Matched citations: HR 34
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017
2016 · fourth_quarter · Firm: WOODBERRY ASSOCIATES
PL 114-255 (HR 34) - 21st Century Cures -- provisions supporting clinical trial research and CDC funding Senate Medical Innovation legislation Clinical Trials -- supporting a federal campaign to promote clinical trial participation Biologic medicines - supporting transparent naming, labeling and indication extrapolation PL 114-254 (HR 2028) Continuing Resolution - funding to implement provisions of the Comprehensive Addiction & Recovery Act (CARA) S. 3040 Labor/HHS/ED Appropriations - support for clinical trials and medical research
Client expense: — · Firm income: $30,000
Matched citations: S. 3040
HR 5 - 21st Century Cures -- provisions supporting clinical trial research and CDC funding Senate Medical Innovation legislation Clinical Trials -- supporting a federal campaign to promote clinical trial participation Biologic medicines - supporting transparent naming, labeling and indication extrapolation S. 524 Comprehensive Addiction & Recovery Act (CARA) S. 3040 Labor/HHS/ED Appropriations - support for clinical trials and medical research
Client expense: — · Firm income: $30,000
Matched citations: HR 5
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017
2016 · third_quarter · Firm: WOODBERRY ASSOCIATES
HR 5 - 21st Century Cures -- provisions supporting clinical trial research and CDC funding Senate Medical Innovation legislation Clinical Trials -- supporting a federal campaign to promote clinical trial participation Biologic medicines - supporting transparent naming, labeling and indication extrapolation S. 524 Comprehensive Addiction & Recovery Act (CARA) S. 3040 Labor/HHS/ED Appropriations - support for clinical trials and medical research
Client expense: — · Firm income: $30,000
Matched citations: S. 3040
Comprehensive Addiction and Recovery Act of 2016
2016 · third_quarter · Firm: WOODBERRY ASSOCIATES
HR 5 - 21st Century Cures -- provisions supporting clinical trial research and CDC funding Senate Medical Innovation legislation Clinical Trials -- supporting a federal campaign to promote clinical trial participation Biologic medicines - supporting transparent naming, labeling and indication extrapolation S. 524 Comprehensive Addiction & Recovery Act (CARA) S. 3040 Labor/HHS/ED Appropriations - support for clinical trials and medical research
Client expense: — · Firm income: $30,000
Matched citations: S. 524
Source: Senate LDA